Celgene Investor
Celgene discovers, develops and commercializes innovative therapies to treat cancer and immune-inflammatory-related diseases.
.png)
Technology:
Pharma
Industry:
CAR-T
Headquarters:
Summit, New Jersey, United States
Founded Date:
1986-01-01
Employees Number:
10001+
Funding Status:
M&A
Number Of Exits:
29
Acquisitions Number:
29
Estimated Revenue:
$10B+
Register and Claim Ownership